WO2006094247A3 - Amniotic membrane extracts, compositions thereof, and methods of use - Google Patents

Amniotic membrane extracts, compositions thereof, and methods of use Download PDF

Info

Publication number
WO2006094247A3
WO2006094247A3 PCT/US2006/007776 US2006007776W WO2006094247A3 WO 2006094247 A3 WO2006094247 A3 WO 2006094247A3 US 2006007776 W US2006007776 W US 2006007776W WO 2006094247 A3 WO2006094247 A3 WO 2006094247A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
amniotic membrane
inflammation
scarring
compositions
membrane extracts
Prior art date
Application number
PCT/US2006/007776
Other languages
French (fr)
Other versions
WO2006094247A2 (en )
Inventor
Scheffer Cg Tseng
David Y Tseng
Wei Li
Hua He
Original Assignee
Tissuetech Inc
Scheffer Cg Tseng
David Y Tseng
Wei Li
Hua He
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells

Abstract

The present invention relates to the prevention and reduction of scarring and inflammation by amniotic membrane extracts or compositions thereof. The invention also relates to the preparation of soluble and fractionated amniotic membrane extracts and the preparation of gels comprising the amniotic membrane extract for enhanced use and application. The invention further provides an extract composition of amniotic membrane that is effective in the prevention and reduction of scarring and inflammation by suppression of TGF-β activity. The invention further provides a method for reducing scarring and inflammation, and enhancing healing of wounds. The invention also provides purified lumican from human AM for the treatment of scarring and inflammation.
PCT/US2006/007776 2005-03-02 2006-03-02 Amniotic membrane extracts, compositions thereof, and methods of use WO2006094247A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US65739905 true 2005-03-02 2005-03-02
US60/657,399 2005-03-02

Publications (2)

Publication Number Publication Date
WO2006094247A2 true WO2006094247A2 (en) 2006-09-08
WO2006094247A3 true true WO2006094247A3 (en) 2006-10-26

Family

ID=36941885

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/007776 WO2006094247A3 (en) 2005-03-02 2006-03-02 Amniotic membrane extracts, compositions thereof, and methods of use

Country Status (1)

Country Link
WO (1) WO2006094247A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9161956B2 (en) 2005-09-27 2015-10-20 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
WO2008060377A3 (en) * 2006-10-04 2008-08-21 Anthrogenesis Corp Placental or umbilical cord tissue compositions
US9175066B2 (en) 2009-04-24 2015-11-03 Tissuetech, Inc. Compositions containing HC-HA complex and methods of use thereof
EP2536827B1 (en) 2010-02-18 2018-01-10 Osiris Therapeutics, Inc. Methods of manufacture of therapeutic products comprising vitalized placental dispersions
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
WO2012170905A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
WO2014040026A3 (en) * 2012-09-10 2015-07-23 Wake Forest University Health Sciences Amniotic membrane and its use in wound healing and tissue engineering constructs
US10016459B1 (en) 2013-03-13 2018-07-10 BioDlogics, LLC Platelet-rich plasma derived from human umbilical cord blood
US9795639B1 (en) 2013-03-16 2017-10-24 BioDlogics, LLC Methods for the treatment of erectile dysfunction by human birth tissue material compostion
US9993506B1 (en) 2013-03-16 2018-06-12 BioDlogics, Inc. Methods for the treatment of degenerative disc diseases by human birth tissue material composition
US10039792B1 (en) 2013-03-16 2018-08-07 Brahm Holdings, Llc Methods for the treatment of inflammation and pain using human birth tissue material composition
EP3019186A4 (en) * 2013-07-12 2017-03-29 Patrick J. Casey Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
CN109069411A (en) * 2016-03-28 2018-12-21 塞尔索·特略 As ophthalmic or placental amnion dressing formulations to enhance healing and equipment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040057938A1 (en) * 2002-09-18 2004-03-25 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040057938A1 (en) * 2002-09-18 2004-03-25 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9161956B2 (en) 2005-09-27 2015-10-20 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods

Also Published As

Publication number Publication date Type
WO2006094247A2 (en) 2006-09-08 application

Similar Documents

Publication Publication Date Title
CA2656915A1 (en) Human protein tyrosine phosphatase inhibitors and methods of use
WO1999003446A3 (en) Antimicrobial cosmetic compositions
JP2005314311A (en) Composition for allergic rhinitis for nasal cavity application
Chandrasekaran Role of tannins in oral health care
JP2002338487A (en) Drug for external use
JP6026540B2 (en) Therapeutic compositions of peripheral ulcer of different causes
CN104666231A (en) Green beans Whitening Mask
WO2006124874A3 (en) Inhibitors of b-raf kinase
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2011141113A3 (en) Combination of vitamin k and nicotinamide
WO2003017826A3 (en) Processed soft tissue for topical or internal application
CN104248546A (en) Bitter orange flower essential oil spot-removal essence
WO2002030443A3 (en) Regulation of human skin healing
WO2003024996A3 (en) Antibacterial macrocycles
CN104887596A (en) Snail raw liquid with effect of full-effect repair, and preparation method thereof
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
WO2010134769A3 (en) Composition for preventing or treating irritable bowel syndrome
WO2009101206A3 (en) Strategies to prevent and/or treat immune responses to soluble allofactors
WO2007038686A3 (en) Amniotic membrane preparations and purified compositions and methods of use
WO2008068408A9 (en) Oral hygiene composition and its use in the treatment of halitosis

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

NENP Non-entry into the national phase in:

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06737006

Country of ref document: EP

Kind code of ref document: A2